Clinical Analysis of Elemene Injection Adjuvant VAD Chemotherapy Treatment Multiple Myeloma

ZHANG Ying-hui; ZHANG Cheng-sheng; MENG Jie

doi:10.11653/syfj2013230313

您当前的位置：

首页 >

文章列表页 >

Clinical Analysis of Elemene Injection Adjuvant VAD Chemotherapy Treatment Multiple Myeloma

更新时间：2024-01-04

- Clinical Analysis of Elemene Injection Adjuvant VAD Chemotherapy Treatment Multiple Myeloma
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 23, Pages: 313-316(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013230313
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
ZHANG Ying-hui, ZHANG Cheng-sheng, MENG Jie. Clinical Analysis of Elemene Injection Adjuvant VAD Chemotherapy Treatment Multiple Myeloma[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 313-316.
DOI：

ZHANG Ying-hui, ZHANG Cheng-sheng, MENG Jie. Clinical Analysis of Elemene Injection Adjuvant VAD Chemotherapy Treatment Multiple Myeloma[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 313-316. DOI： 10.11653/syfj2013230313.

摘要

目的: 研究榄香烯注射液辅助VAD化疗的临床疗效及安全性。方法: 选择在我院就诊的多发性骨髓瘤患者作为研究对象，随机分为给予榄香烯注射液辅助VAD化疗的观察组和VAD化疗的对照组，VCD化疗采用静脉注射长春新碱（0.4 mg）、阿霉素（9 mg）、口服地塞米松（40 mg），榄香烯注射液（0.4 g）静脉滴注。观察缓解情况、免疫功能及不良反应。结果: 观察组的完全缓解率（38.46%）、部分缓解率（46.25%）以及CD3+（68.38±9.03）%，CD4+（47.18±8.49）%，CD4+/CD8+（2.17±0.42），自然杀伤细胞（NK）（9.31±1.34）%，肿瘤坏死因子-α（TNF-α）（1.53±0.21）ng·L-1，提高稳定率（92.31%）等高于对照组;CD8+（21.75±5.68）%以及头痛头晕（23.08%）、消化道症状（7.69%）、肾功能损害（7.69%）、肝功能损害（7.69%）、心功能损害（15.38%）、骨髓抑制（7.69%）均明显少于对照组。结论: 榄香烯注射液辅助VAD化疗能够提高化疗缓解率、改善免疫功能、减少不良反应，具有积极的临床价值。

Abstract

Objective: To study the clinical efficacy and safety of elemene injection adjuvant VAD chemotherapy. Method: Multiple myeloma patients were collected and randomLy divided into observation group given elemene injection adjuvant VAD chemotherapy and Vcontrol group given VAD chemotherapy. VCD chemotherapy using intravenous vincristine (0.4 mg)

adriamycin (9 mg)

oral dexamethasone (40 mg)

Elemene injection intravenous drip (0.4 g). Then remission

immune function and adverse reaction were observed. Result: Tcomplete remission rate (38.46% )

partial remission rate (46.25% )and CD3+(68.38±9.03)%

CD4+(47.18±8.49)%

CD4+/CD8+(2.17±0.42)

natural killer cells(NK)(9.31±1.34)%

tumor necrosis factor-α(TNF-α)(1.53±0.21)ng· L-1 levels

Improve the stability factor (92.31% ) of observation group were higher than control group;CD8+(21.75±5.68)%

Headache dizziness (23.08% )

gastrointestinal symptoms (7.69% )

renal impairment (7.69% )

liver function damage (7.69% )

heart function damage (15.38% )

bone marrow suppression (7.69% ) were significantly less thancontrol group. Conclusion: Elemene injection adjuvant VAD chemotherapy has positive clinical value for it can improve remission and immune function

reduce adverse reaction.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Jianpi Bushen Prescription on Hematopoiesis and Immune System in Tumor Patients After Radiotherapy

Elemene Enhances Anti-glioma Effect of Cabazitaxel and Its Dual-targeted Cationic Liposome Preparation Optimization and in Vitro Pharmacodynamic Evaluation

Effect of Modified Gualou Zhishitang Combined with Piperacillin Sodium and Tazobactam Sodium on Immune Function and Serum Levels of Inflammatory Cytokines in Patients with Stroke-associated Pneumonia with Syndrome of Phlegm-heat Accumulation in Lung

Clinical Efficacy of Qimai Qinlou Prescription in Treating Elderly Community-acquired Pneumonia （Non-severe） with Qi and Yin Deficiency and Phlegm-heat Obstructing Lung Syndrome

Anti-Allergic Rhinitis Mechanism of Bikangfu via Regulation of IL-35/STAT3， Inhibition of Eosinophil Activation and Improvement of Immune Function

Related Author

SUN Junyang

HE Dongchu

YIN Liyan

WANG Rongrong

LI Jie

XIE Tian

WANG Yongfei

ZHU Qinxian

Related Institution

Central Theater General Hospital of PLA

Hubei University of Chinese Medicine

Chengdu University of TCM

School of Pharmacy，Hangzhou Normal University

School of Traditional Chinese Medicine（TCM）， Guangdong Pharmaceutical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰